Should You Buy Cronos Group (TSX:CRON) on the Dip?

Cronos Group (TSX:CRON)(NASDAQ:CRON) is perhaps the most expensive cannabis stock as far as forward valuations are concerned. It’s also been the target of several analyst downgrades thanks to its premium multiple to its peers. With the entire sector experiencing a pullback during the past few weeks, here are two reasons why you should buy Cronos, and one reason why you…

Read More

Is Aurora Cannabis Inc (TSX:ACB) Working on a Big Deal?

Aurora Cannabis (TSX:ACB)(NYSE:ACB) has been making some big, subtle moves lately. In March, the company announced that it was bringing on billionaire investor Nelson Peltz as a strategic advisor. Normally, that’s a vague position and can mean anything and everything. However, in this case, it was noticeably different. For one, Peltz could end up being a big shareholder of the…

Read More

Cannabis Stocks: 3 Things to Know Before Buying

Recent market action has shown that at least some cannabis stocks may be taking a breather. And while past performance in certainly exceptional, we need to focus on what we can expect for future performance. Canopy Growth (TSX:WEED)(NYSE:CGC) stock is down 6% in the last month and Cronos Group (TSX:CRON)(NASDAQ:CRON) stock is down 21%. Let’s look at three things you…

Read More

Aurora Cannabis (TSX:ACB) About to Get Transformed

Marijuana producer and aggressive growth stock Aurora Cannabis (TSX:ACB)(NYSE:ACB) has been in the news lately over its recent connected actions towards strategic partnerships since engaging a professional investment manager, its latest lodging of a $750 million shelf prospectus, and the latest personnel hire, which indicate a serious commitment to business transformation. The company had lagged behind in forming strategic partnerships…

Read More